Exiqon said last week that it has established a center of excellence at the Oncogenomics Core Facility at the Sylvester Comprehensive Care Center at the University of Miami Miller School of Medicine.
As part of Exiqon's certified service provider program, the Oncogenomics Core Facility at U of Miami will offer real-time PCR services based on Exiqon's miRcury LNA Universal RT microRNA PCR product line.
"The Oncogenomics Core Facility has had great success over the last several months using the Exiqon LNA qPCR platform and we are excited to be a center of excellence," Toumy Guettouche, director of the OCF, said in a statement.
Vedbaek, Denmark-based Exiqon said that it introduced the COE program in response to an increased demand for its Locked Nucleic Acid products and services.
The OCF at U of Miami will become Exiqon's second US-based COE. In November 2009 the company said that Harvard University's ICCB-Longwood Screening Facility would serve as a microRNA screening COE by offering Exiqon's LNA microRNA Knockdown Library for high-throughput screening of small molecule and RNAi libraries.
In June, the company named Sweden's Tataa Biocenter and South Korea's Bioneer centers of excellence. Tataa is marketing qPCR services based on the company's microRNA LNA qPCR product line, and Bioneer is marketing in situ hybridization services based on Exiqon's LNA microRNA and mRNA detection product line.